05/22/19 Synthetic biology pioneer Amyris NASDAQ AMRS has taken investors on a wild ride over the past year Shares have touched highs above 9 and dipped to lows under 2 as analysts attempted to sort out the impact from restated financial statements coming and going debt maturities
05/06/19 Amyris AMRS is expected to deliver a year over year increase in earnings on higher revenues when i t report s results for the quarter ended March 2019 This widely known consensus outlook gives a good sense of the company s earnings picture but how the actual results compare to these
05/02/19 As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy they expect to make money So let s look at two noteworthy recent insider buys On Monday Amyris AMRS s Director Frank Kung made a 4 35M purchase of AMRS buying 913
AMRS - Amyris